Vasopressin als Reservevasopressor
暂无分享,去创建一个
[1] H. Mann,et al. Update on the management of cardiogenic shock , 2006, Current opinion in critical care.
[2] P. Radermacher,et al. Catecholamines and vasopressin during critical illness. , 2006, Endocrinology and metabolism clinics of North America.
[3] H. Ross,et al. Effect of vasopressin on hemodynamics in patients with refractory cardiogenic shock complicating acute myocardial infarction. , 2005, The American journal of cardiology.
[4] V. Wenzel,et al. Arginine vasopressin in 316 patients with advanced vasodilatory shock* , 2005, Critical care medicine.
[5] M. Gheorghiade,et al. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes. , 2005, The American journal of cardiology.
[6] C. Hogue,et al. Vasopressin during spinal anesthesia in a patient with primary pulmonary hypertension treated with intravenous epoprostenol. , 2004, Anesthesia and analgesia.
[7] W. Schobersberger,et al. Does Arginine Vasopressin Influence the Coagulation System in Advanced Vasodilatory Shock with Severe Multiorgan Dysfunction Syndrome? , 2004, Anesthesia and analgesia.
[8] P. Factor,et al. Role of vasopressin in the management of septic shock , 2004, Intensive Care Medicine.
[9] S. Ho,et al. Low-dose vasopressin infusion can be an alternative in treating patients with refractory septic shock combined with chronic pulmonary hypertension--a case report. , 2003, Acta anaesthesiologica Sinica.
[10] M. Dünser,et al. Arginine Vasopressin in Advanced Vasodilatory Shock: A Prospective, Randomized, Controlled Study , 2003, Circulation.
[11] M. Westphal,et al. Terlipressin dose response in healthy and endotoxemic sheep: impact on cardiopulmonary performance and global oxygen transport , 2003, Intensive Care Medicine.
[12] P. Wouters,et al. Effects of vasopressin on right ventricular function in an experimental model of acute pulmonary hypertension* , 2002, Critical care medicine.
[13] M. Dünser,et al. Cardiac performance during vasopressin infusion in postcardiotomy shock , 2002, Intensive Care Medicine.
[14] D. Landry,et al. The pathogenesis of vasodilatory shock. , 2001, The New England journal of medicine.
[15] M. Dünser,et al. The Effects of Vasopressin on Systemic Hemodynamics in Catecholamine-Resistant Septic and Postcardiotomy Shock: A Retrospective Analysis , 2001, Anesthesia and analgesia.
[16] M. Oz,et al. Vasopressin as an alternative to norepinephrine in the treatment of milrinone‐induced hypotension , 2000, Critical care medicine.
[17] M. Oz,et al. Vasopressin pressor hypersensitivity in vasodilatory septic shock. , 1997, Critical care medicine.
[18] B. Walker,et al. Enhanced pulmonary arterial dilation to arginine vasopressin in chronically hypoxic rats. , 1994, The American journal of physiology.
[19] H. Schaff,et al. Arginine vasopressin induces endothelium-dependent vasodilatation of the pulmonary artery. V1-receptor-mediated production of nitric oxide. , 1993, Chest.